Archive

Research Article Open Access

Differential Risky Behaviors among HIV Positive and HIV Negative People

Celine Nguefeu Nkenfou, Josiane Gouekem, Antoine Socpa, Blandine Nkenfou Kampa, Elvis Ndukong Ndzi, Alexandre Nkoum and Alexis Njolo
Int J Virol AIDS Volume 4, Issue 1

Abstract: HIV positive and HIV negative people were recruited in the capital city of Cameroon. Data were collected through a structured questionnaire, pretested and validated, before and after the knowledge of HIV status. The information collected include: Age at first sexual intercourse, number of sexual partners, usage of condoms and frequency of sexual intercourses.

PDF   | Full Text   DOI: 10.23937/2469-567X/1510037

Research Article Open Access

p53 Expression Activation of HIV-1 Latency in U1 Cells

Xue Wang , Jiangqin Zhao, Christelle Mbondji and Indira Hewlett
Int J Virol AIDS Volume 4, Issue 1

Abstract: Latent infection is a major barrier for cure of HIV-1 infection. HIV-1 is capable of establishing latency when its host cells undergo apoptosis and initiate replication in response to this effect. HIV infection results in increased p53 expression that enhances replication in primary infection.

PDF   | Full Text   DOI: 10.23937/2469-567X/1510036

Letter Open Access

Concurrent HIV and Zika Virus Infection, A Problem to be Address in HIV Medicine

Beuy Joob and Viroj Wiwanitkit
Int J Virol AIDS Volume 4, Issue 1

Abstract: The concurrences between HIV infection and Zika virus infection are already reported [1-3]. The first case report was from Brazil. There is no significant important clinical observation on the concurrence. The problem in the HIV pregnant woman is also already reported.

PDF   | Full Text   DOI: 10.23937/2469-567X/1510035

Case Report Open Access

Dual Cytomegalovirus and Aspergillus Pneumonia Following Influenza B Infection in a Patient with Polyarteritis Nodosa

Chiu-Yin Yeh, Hsi-Hsing Yang and Wen-Liang Yu
Int J Virol AIDS Volume 4, Issue 1

Abstract: Polyarteritis Nodosa (PAN) is a systemic necrotizing vasculitis that might require immunosuppressive therapy. We report on a 72-year-old woman of PAN with influenza B infection, who developed dual cytomegalovirus and Aspergillus pneumonia in the later course.

PDF   | Full Text   DOI: 10.23937/2469-567X/1510034

Letter to Editor Open Access

Acute Pulmonary Embolism in Dual Dengue Fever and Influenza B Infection

Wen Chi Hsu and Wen Liang Yu
Int J Virol AIDS Volume 4, Issue 1

Abstract: Acute Pulmonary Embolism (PE) is a life-threatening condition and the common cause of death is due to obstruction of main pulmonary vessels by the embolus, resulting in pulmonary hypertension followed by right-sided heart failure.

PDF   | Full Text   DOI: 10.23937/2469-567X/1510033

Research Article Open Access

Etiologic Viral Characterization of Acute Respiratory Infections in Children in the Western Amazon-Brazil

Santos AO, Botelho-Souza LF, Lopes DS, Rodrigues GT, Queiroz JAS, Matos NB, Salcedo JMV and Vieira DS
Int J Virol AIDS Volume 4, Issue 1

Abstract: Acute Respiratory Infections (ARIs) are classified according to the compromised anatomical site. The etiology can be associated with viruses, bacteria and fungi. The etiological agents that are responsible for the highest incidence in children, around 50 to 90% of occurrences, are viruses.

PDF   | Full Text   DOI: 10.23937/2469-567X/1510032

LETTER TO EDITOR Open Access

Hepatitis B Induced Kaposi Sarcoma Flare

Ezgi Ozkur , Mehmet Salih Gurel, Sevil Savas, Ayse Esra Koku Aksu and Sumeyre Seda Ertekin
Int J Virol AIDS Volume 4, Issue 1

Abstract: Kaposi Sarcoma (KS) is a malignant disease that originates from the vascular endothelium and has a very variable clinical course. KS is a vascular endothelial malignancy and the neoplastic cells are closely related to lymphatic endothelial cells. Although HHV-8 is found in the vast majority of all types of KS, there is no agreement on the exact mechanism of HHV-8 in KS.

PDF   | Full Text   DOI: 10.23937/2469-567X/1510031

Original Research Open Access

Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA

Tomas Mellberg, Jon Krabbe, Maria J Buzon, Ulrika Noborg, Magnus Lindh, Staffan Nilsson, Bo Svennerholm and Magnus Gisslen
Int J Virol AIDS Volume 4, Issue 1

Abstract: Correct measurements of residual viremia and reservoir size are crucial in HIV-1 eradication trials and there is a need for sensitive and automated assays. The increasing worldwide diversity of HIV-1 subtypes stresses the importance of subtype independent assays.

PDF   | Full Text   DOI: 10.23937/2469-567X/1510030

Research Article Open Access

Virologic Response and Survival Analysis of 281 HbsAg Treatment Naive Patients on Lamivudine Monotherapy in Sierra Leone

Jia B Kangbai, Isata Victoria Mandoh and Peter Bai James
Int J Virol AIDS Volume 4, Issue 1

Abstract: More than 350 million people are infected with Hepatitis B Virus (HBV) globally. The main aim of any chronic hepatitis B therapy is to prevent liver cirrhosis and its sequelae, including Hepatocellular Carcinoma (HCC).

PDF   | Full Text   DOI: 10.23937/2469-567X/1510029

Volume 4
Issue 1